Targeting ferroptosis with the lipoxygenase inhibitor PTC 041 as a therapeutic strategy for the treatment of Parkinson's disease PLOS One Best Glutathione Supplement 4 Recommendations in 2026 Parkinson's disease research moves on briskly The Lancet Randomized, double'blind, pilot evaluation of intravenous glutathione in Parkinson's disease